Form type | Sec Links | Description | Filing date | Reporting date |
---|---|---|---|---|
SC 13D/A | Report | Apr 15, 2024 | ||
SC 13D/A | Report | Apr 7, 2023 | ||
SC 13D/A | Report | Jul 28, 2022 | ||
SC 13D/A | Report | Apr 15, 2022 | ||
SC 13D/A | Report | Sep 24, 2021 | ||
SC 13D/A | Report | Feb 9, 2021 | ||
SC 13D/A | Report | Jan 22, 2021 | ||
SC 13D/A | Report | Jan 8, 2021 | ||
SC 13D/A | Report | Apr 27, 2020 | ||
SC 13D/A | Report | Jan 6, 2020 | ||
SC 13D/A | Report | Sep 13, 2019 | ||
SC 13D/A | Report | Sep 13, 2019 | ||
SC 13D/A | Report | Jul 5, 2019 | ||
SC 13D/A | Report | Jul 2, 2019 | ||
SC 13D/A | Report | Feb 12, 2019 | ||
SC 13D/A | Report | Aug 22, 2018 | ||
SC 13D/A | Report | May 18, 2018 | ||
SC 13D/A | Report | Apr 3, 2018 | ||
SC 13D/A | Report | Mar 30, 2018 | ||
SC 13D/A | Report | Nov 15, 2017 | ||
SC 13D | Report | Sep 8, 2016 | ||
SC 13D/A | Report | BIOTIME SC 13DA NO1 8-25-2016 (ONCOCYTE) | Aug 29, 2016 | |
SC 13D | Report | BIOTIME, INC. SC 13D 12-30-2015 (ONCOCYTE CORPORATION) | Dec 31, 2015 |